Article Details
Retrieved on: 2022-08-15 12:08:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Clinical trials of Bharat Biotech's intranasal COVID vaccine candidate as a primary (two) dose and a heterologous booster dose have been completed ...
Article found on: www.thehindu.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here